[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more Oncodesign’s Pharmimage® technology module is a pharmaco-imaging module designed to monitor the effect of treatments and to define effective translational biomarkers in precision medicine..
It includes translational, optical (bioluminescence, fluorescence), functional and molecular (MRI, PET, SPECT, CT scanner, MRI/PET coupling) multi-modal imaging capabilities, adapted to small rodents and primates.
Pharmimage® makes it possible to search for biomarkers using non-invasive, whole-body techniques:
We can help you design and carry out nuclear radiolabeling for your molecules of interest, whether chemical or biological. Our radiochemistry laboratories are licensed to handle all isotopes used in imaging and nuclear medicine and can produce batches for preclinical and clinical use.
Pharmimage® handles the transition between the preclinical and clinical phases, in particular through the Georges François Leclerc Cancer Control Center and the Dijon University Hospital in France..